Inflammatory bowel disease patient perceptions of diagnostic and monitoring tests and procedures.
Adolescent
Adult
Canada
/ epidemiology
Female
Health Knowledge, Attitudes, Practice
Humans
Incidence
Inflammatory Bowel Diseases
/ diagnosis
Male
Middle Aged
Monitoring, Physiologic
Patient Acceptance of Health Care
Patient Education as Topic
Perception
Prevalence
Quality of Life
Surveys and Questionnaires
Treatment Refusal
Young Adult
Diagnostic
Inflammatory bowel disease
Monitoring
Procedures
Tests
Journal
BMC gastroenterology
ISSN: 1471-230X
Titre abrégé: BMC Gastroenterol
Pays: England
ID NLM: 100968547
Informations de publication
Date de publication:
13 Feb 2019
13 Feb 2019
Historique:
received:
09
10
2018
accepted:
29
01
2019
entrez:
15
2
2019
pubmed:
15
2
2019
medline:
5
3
2019
Statut:
epublish
Résumé
Inflammatory Bowel Disease (IBD) with its high incidence and prevalence rates in Canada generates a heavy burden of tests and procedures. The purpose of this study is to gain a better understanding of the transfer of information from physician to patient, as well as the patient understanding and perceptions about the tests and procedures that are ordered to them in the context of IBD diagnosis and monitoring. An online questionnaire was completed by 210 IBD patients in Canada. Information on the five most-often used tests or procedures in IBD diagnosis/monitoring was collected. These include: general blood test, colonoscopy, colon biopsy, medical imaging and stool testing. The general blood test is both the most ordered and most refused tool. It is also the one with which patients are the least comfortable, the one that generates the least concern and the one about which physicians provide the least information. The stool test is the test/procedure with which patients are the most comfortable. Procedures raise more concerns among patients and physicians provide more information about why they are needed, their impact and the risks they present. Very little information is provided to patients about the risks of having false positives or negative tests. This study provides an initial understanding of patient perceptions, the transfer of information from a physician to a patient and a patient's understanding of the tests and procedures that will be required to treat IBD throughout what is a lifelong disease. The present study takes a first step in better understanding the acceptance of the test or procedure by IBD patients, which is essential for them to adhere to the monitoring process.
Sections du résumé
BACKGROUND
BACKGROUND
Inflammatory Bowel Disease (IBD) with its high incidence and prevalence rates in Canada generates a heavy burden of tests and procedures. The purpose of this study is to gain a better understanding of the transfer of information from physician to patient, as well as the patient understanding and perceptions about the tests and procedures that are ordered to them in the context of IBD diagnosis and monitoring.
METHODS
METHODS
An online questionnaire was completed by 210 IBD patients in Canada. Information on the five most-often used tests or procedures in IBD diagnosis/monitoring was collected. These include: general blood test, colonoscopy, colon biopsy, medical imaging and stool testing.
RESULTS
RESULTS
The general blood test is both the most ordered and most refused tool. It is also the one with which patients are the least comfortable, the one that generates the least concern and the one about which physicians provide the least information. The stool test is the test/procedure with which patients are the most comfortable. Procedures raise more concerns among patients and physicians provide more information about why they are needed, their impact and the risks they present. Very little information is provided to patients about the risks of having false positives or negative tests.
CONCLUSIONS
CONCLUSIONS
This study provides an initial understanding of patient perceptions, the transfer of information from a physician to a patient and a patient's understanding of the tests and procedures that will be required to treat IBD throughout what is a lifelong disease. The present study takes a first step in better understanding the acceptance of the test or procedure by IBD patients, which is essential for them to adhere to the monitoring process.
Identifiants
pubmed: 30760205
doi: 10.1186/s12876-019-0946-8
pii: 10.1186/s12876-019-0946-8
pmc: PMC6374885
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
30Références
Arch Dis Child. 2004 Jan;89(1):69-71
pubmed: 14709513
BMJ. 2005 Mar 19;330(7492):644-8
pubmed: 15774996
Ann Fam Med. 2005 May-Jun;3(3):209-14
pubmed: 15928223
Gut. 2009 Jun;58(6):859-68
pubmed: 19136508
Inflamm Bowel Dis. 2010 Jan;16(1):112-24
pubmed: 19653289
Ann Oncol. 2010 Nov;21(11):2262-6
pubmed: 20423914
Inflamm Bowel Dis. 2011 Feb;17(2):590-8
pubmed: 20848545
Can J Gastroenterol. 2010 Nov;24(11):651-5
pubmed: 21157579
Gastroenterol Res Pract. 2011;2011:492034
pubmed: 21912537
Gastroenterology. 2012 Jan;142(1):46-54.e42; quiz e30
pubmed: 22001864
BMC Res Notes. 2012 Oct 31;5:605
pubmed: 23110849
Can J Gastroenterol. 2012 Nov;26(11):811-7
pubmed: 23166905
Bone Marrow Transplant. 2013 Aug;48(8):1091-7
pubmed: 23419436
Eur J Gastroenterol Hepatol. 2013 Aug;25(8):964-72
pubmed: 23660935
J Clin Nurs. 2014 Jun;23(11-12):1718-25
pubmed: 24004406
J Crohns Colitis. 2014 Oct;8(10):1281-6
pubmed: 24662394
Clin Gastroenterol Hepatol. 2015 Feb;13(2):322-329.e1
pubmed: 25041865
Rom J Intern Med. 2014;52(3):151-7
pubmed: 25509558
Am Psychol. 2015 Feb-Mar;70(2):105-18
pubmed: 25730718
Can J Gastroenterol Hepatol. 2015 Mar;29(2):77-84
pubmed: 25803017
Am J Gastroenterol. 2015 Jul;110(7):1014-21
pubmed: 25823770
Patient. 2016 Feb;9(1):79-89
pubmed: 25963447
Am J Gastroenterol. 2015 Jun;110(6):802-19; quiz 820
pubmed: 25964225
Clin Imaging. 2016 Mar-Apr;40(2):339-43
pubmed: 26112898
Clin J Pain. 2015 Oct;31(10 Suppl):S3-11
pubmed: 26352920
World J Gastroenterol. 2015 Oct 28;21(40):11246-59
pubmed: 26523100
Patient Educ Couns. 2016 Apr;99(4):651-658
pubmed: 26597383
World J Gastroenterol. 2016 Jan 21;22(3):917-32
pubmed: 26811637
World J Gastroenterol. 2016 Feb 21;22(7):2165-78
pubmed: 26900282
World J Radiol. 2016 Feb 28;8(2):124-31
pubmed: 26981221
Cogn Behav Ther. 2016 Apr;45(3):217-35
pubmed: 27007463
Curr Drug Targets. 2018;19(7):777-781
pubmed: 27033185
J Adolesc Health. 2016 Oct;59(4):479-81
pubmed: 27506279
Clin Med Insights Gastroenterol. 2016 Aug 18;9:51-62
pubmed: 27656094
Int J Behav Med. 2017 Apr;24(2):205-214
pubmed: 27757843
JBI Libr Syst Rev. 2011;9(19):631-678
pubmed: 27820215
Patient Prefer Adherence. 2016 Nov 23;10:2387-2396
pubmed: 27920505
World J Gastrointest Endosc. 2016 Dec 16;8(20):723-732
pubmed: 28042386
Am J Gastroenterol. 2017 Jul;112(7):1120-1134
pubmed: 28417994
Patient Prefer Adherence. 2017 May 24;11:985-994
pubmed: 28579761
Pharmacogenomics J. 2018 Apr;18(2):308-318
pubmed: 28607504
Patient Educ Couns. 2018 Feb;101(2):331-339
pubmed: 28760459
J Anxiety Disord. 2017 Oct;51:65-71
pubmed: 28780134
Clin Ter. 2017 Nov-Dec;168(6):e401-e405
pubmed: 29209693
Acta Biomed. 2018 Jan 16;88(4):414-425
pubmed: 29350655
Acta Clin Croat. 2017 Dec;56(4):765-772
pubmed: 29590734